SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that regulatory clearances have been issued with respect to four products Merit owns or holds the rights […]
Other News
MedHub Announces Completion of Its First Validation Clinical Study in Israel
TEL-AVIV, Israel, Feb. 20, 2020 /PRNewswire/ — MedHub develops an advanced AI-based solution for interventional cardiologists. AutocathFFR is the only fully workflow-integrated system that enables cardiologists to take better decisions during the diagnostic procedure by providing them with automated image-based stenosis detection and FFR measurement of each captured stenosis. MedHub successfully completed […]
AliveCor Receives Approval to Launch KardiaMobile in Mexico
The company expands its personalized, mobile ECG now to over 25 countries around the world MEXICO CITY and MOUNTAIN VIEW, Calif., Feb. 19, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, announced approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), to launch KardiaMobile in Mexico. […]
Moleculin Announces Positive Independent Report of No Cardiotoxicity in Annamycin Phase 1 To Date
Supports Moleculin’s Claim that Annamycin is a “Next Generation” Anthracycline HOUSTON, Feb. 20, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that it has received an independent assessment of the absence of […]
Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
Data Provide Preliminary Evidence of Efficacy of the Investigational Peregrine System Kit SAN JOSE, Calif., Feb. 20, 2020 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company’s CE-marked […]
Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff
VANCOUVER and MINNEAPOLIS, Feb. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it will […]
Novoheart Named 2020 Venture 50 Company, Ranked Among Year’s Top Performing Stocks in Life Sciences
Novoheart Among Top 10 TSX-V Performers in Clean Technology & Life Sciences Sector Ranking based on share price increase, trading volume and market capitalization VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, is pleased to announce […]
Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
Fourth Quarter 2019 Revenues of $681.0 million, up 6.1% Versus Prior Year Period; up 7.1% on a Constant Currency Basis Fourth Quarter 2019 GAAP Diluted EPS from Continuing Operations of $2.28, up 21.9% Versus Prior Year Period Fourth Quarter 2019 Adjusted Diluted EPS from Continuing Operations of $3.28, up 18.4% […]
HeartVista Announces Formation of Medical and Scientific Advisory Board with Leaders from Stanford University and the University of Wisconsin
LOS ALTOS, Calif.–(BUSINESS WIRE)–HeartVista, a pioneer in AI-assisted MRI solutions, announced the formation of its Medical and Scientific Advisory Board, including notable thought leaders from Stanford University and the University of Wisconsin. “The past year was an inflection point for HeartVista, which was full of significant milestones as we received […]
Endologix Reports Fourth Quarter and Fiscal Year 2019 Financial Results
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019. Global revenue in the fourth quarter of 2019 was $35.8 million, a 3.0% increase from $34.7 million […]
Recent
New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Popular
- No commented posts yet